Description
Drug Development Pathways provides a comprehensive overview of how a drug progresses from discovery through regulatory approval and beyond. Participants explore key development phases, regulatory requirements, risk mitigation strategies, and the roles of cross-functional teams and vendors. The course also examines post-approval considerations and the historical context behind U.S. FDA regulations.
Schedule (virtual)
Thursday, March 5, 2026 | 9:00–11:30 AM
Thursday, March 12, 2026 | 9:00–11:30 AM
Thursday, March 19, 2026 | 9:00–11:30 AM